Company / Operating Cash Flow
INTERPACE BIOSCIENCES, INC. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$5.8M
FY2025
5-year range
-$8.7M / $5.8M
FY2021-FY2025
Trend
+25.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow has increased for 6 consecutive years, from -$19M in FY2019 to $6M in FY2025.
Based on SEC 10-K filings.
$6M in FY2025.
Improved from $2M to $6M over the past 2 years.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- INTERPACE BIOSCIENCES, INC.'s operating cash flow has grown for 6 consecutive years.
- In FY2025, operating cash flow increased 25.5% year-over-year.
- Lowest operating cash flow in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score -2.84 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.8M | +25.5% |
| FY2024 | $4.6M | +200.9% |
| FY2023 | $1.5M | +120.1% |
| FY2022 | -$7.7M | +11.8% |
| FY2021 | -$8.7M | +37.6% |
| FY2020 | -$14.0M | +26.3% |
| FY2019 | -$19.0M | -118.6% |
| FY2018 | -$8.7M | +43.2% |
| FY2017 | -$15.3M | -100.6% |
| FY2016 | -$7.6M | +61.7% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026